Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rajkumar

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survivalA Dispenzieri, M Q Lacy, R A Kyle, et al.
Leukemia|April 12, 2003
Thalidomide as initial therapy for early-stage myelomaS V Rajkumar, M A Gertz, M Q Lacy, et al.
Leukemia|July 4, 2008
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemC L H Snozek, J A Katzmann, R A Kyle, et al.
Leukemia|March 13, 2014
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myelomaW I Gonsalves, S V Rajkumar, V Gupta, et al.
Leukemia & Lymphoma|December 28, 1999
Clinical significance of the translocation (11;14)(q13;q32) in multiple myelomaR Fonseca, J D Hoyer, P Aguayo, et al.
Bone Marrow Transplantation|December 2, 2000
Effect of complete response on outcome following autologous stem cell transplantation for myelomaS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Leukemia|June 4, 2010
Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myelomaS Kumar, L Zhang, A Dispenzieri, et al.
Bone Marrow Transplantation|May 11, 2004
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapyS Kumar, M Q Lacy, A Dispenzieri, et al.
Bone Marrow Transplantation|August 3, 2004
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myelomaS Kumar, M Q Lacy, A Dispenzieri, et al.
Leukemia|May 8, 2013
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myelomaG Srivastava, V Rana, M Q Lacy, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survivalA Dispenzieri, M Q Lacy, R A Kyle, et al.
Leukemia|April 12, 2003
Thalidomide as initial therapy for early-stage myelomaS V Rajkumar, M A Gertz, M Q Lacy, et al.
Leukemia|July 4, 2008
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemC L H Snozek, J A Katzmann, R A Kyle, et al.
Leukemia|March 13, 2014
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myelomaW I Gonsalves, S V Rajkumar, V Gupta, et al.
Leukemia & Lymphoma|December 28, 1999
Clinical significance of the translocation (11;14)(q13;q32) in multiple myelomaR Fonseca, J D Hoyer, P Aguayo, et al.
Bone Marrow Transplantation|December 2, 2000
Effect of complete response on outcome following autologous stem cell transplantation for myelomaS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Leukemia|June 4, 2010
Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myelomaS Kumar, L Zhang, A Dispenzieri, et al.
Bone Marrow Transplantation|May 11, 2004
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapyS Kumar, M Q Lacy, A Dispenzieri, et al.
Bone Marrow Transplantation|August 3, 2004
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myelomaS Kumar, M Q Lacy, A Dispenzieri, et al.
Leukemia|May 8, 2013
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myelomaG Srivastava, V Rana, M Q Lacy, et al.
Pageof 17